The molecular pathology of small round-cell tumours-relevance to diagnosis, prognosis, and classification

Journal of Pathology

Volumn 178, Issue 2, 1996, Pages 116-121

  McManus, Aidan P ^a   Gusterson, Barry A ^a   Ross Pinkerton, C ^a   Shipley, Janet M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CHROMOSOME TRANSLOCATION; EWING SARCOMA; GENE FUSION; HUMAN; HUMAN TISSUE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; ROUND CELL TUMOR;

BONE NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; NEUROBLASTOMA; PROGNOSIS; RHABDOMYOSARCOMA; SARCOMA, EWING'S; TRANSLOCATION, GENETIC;

EID: 0030024740     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199602)178:2<116::AID-PATH494>3.0.CO;2-H     Document Type: Article

References (80)

1. Variend S Small cell tumours in childhood: a review. J Pathol 1985; 145: 1-25
2. Stiller C Aetiology and epidemiology In: Plowman PH, Pinkerton CR, eds Paediatric Oncology: Clinical Practice and Controversies. London Chapman Hall, 1992; 1-24.
3. Pinkerton CR. Pritchard-Joncs K, Carter RL, Cooper C, McManus AP Small round-cell tumours of childhood Lancet 1994; 344: 725-729
4. Douglass EC Chromosomal rearrangements in Ewing's sarcoma and peripheral neuroectodermal tumor (PNET). Semin Dev Biol 1990, 1: 393-396
5. Taylor CPF, McGuckin AG, Bown NP, Reid MM, Malcolm AJ Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow. Br J Cancer 1994, 69: 445-451
6. Enzinger FM, Weiss SW. Soft Tissue Tumors. 3rd edn. Missouri: MosbyYear Book, 1995
7. Jurgens HF. Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Curr Opin Oncol 1994; 6: 391-396.
8. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral euroepithelioma Am J Surg Pathol 1994, 18: 486-494.
9. Horowitz ME, Malawer MM, Delaney TF, Tsokos MG. Ewing's sarcoma family of tumors. Ewing's sarcoma of bone and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplacks DG, eds. Principles and Practice of Paediatric Oncology Philadelphia: J. B Lippincott, 1993; 795-821.
10. Delattre O, Zucman J, Plougastel B, et al Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-165.
11. Ohno T, Rao VN, Reddy ESP EWS/FLI-1 chimeric protein is a transcriptional activator. Cancer Res 1993, 53: 5859-5863.
12. Zucman J, Melot T. Desmazc C, et al Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993; 12: 4481-4487.
13. Dunn T, Praissman L, Hagag N, Viola MV ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet Cytogenet 1994; 76: 19-22.
14. Jeon IS, Davis JN. Braun BS, et al A variant Ewing's sarcoma translocation (7,22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995; 10: 1229-1234.
15. Giovannini M, Selleri L, Biegel JA, Scotlandi K, Emanuel BS, Evans GA Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumours J Clin Invest 1992; 90: 1911-1918
16. Desmaze C, Zucman J. Delattre O, Thomas G, Aurias A Unicolor and bicolor in situ hybridisation in the diagnosis of peripheral neuroepithelioma and related tumors Gene Chromosome Cancer 1992, 5: 30-34.
17. Taylor CF, Patel K, Jones T, Kiely F, Stavola BLD, Sheer D Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t( 11 ;22) using fluorescence in situ hybridisation. Br J Cancer 1993; 67: 128-133.
18. Desmaze C, Zucman J, Delattre O, Thomas G. Aurias A Interphase molecular cytogenetics of Ewing's sarcoma and peripheral neuroepithelioma t(11;22) with flanking and overlapping cosmid probes. Cancer Genet Cytogenet 1994; 74: 13-18
19. McManus AP, Gusterson BA, Pinkerton CR, Shipley JM. Diagnosis of Ewing's sarcoma and related tumours by fluorescence in situ hybridisation detection of chromosome 22ql2 translocations on tumour touch imprints. J Pathol 1995. 176: 137-142
20. Downing JR. Head DR, Parham DM, et al Detection of the (11;22)(q24,q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 1993, 143: 1294-1300.
21. Sorensen PHB. Lui XF, Delattre O, el al Reverse transcription PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood Diagn Mol Pathol 1993;
22. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors - a subgroup of small round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331: 294-299.
23. Zoubek A, Pfleiderer C, Salzer-Kuntschik M, et al Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br J Cancer 1994; 70: 908-913.
24. Fellinger EJ. Garin-Chesa P, Sui SL, DeAngelis P. Lane JM, Rettig WJ. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen. Cancer Res 1991; 51: 336-340.
25. Gelin C, Aubrit F, Phalipon A, et al The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 1989; 8: 3253-3259.
26. Ambros IM, Ambros PF, Strehl S. Kovar H, Gadner H, Salzer-Kuntschik M MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors: evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration Cancer 1991; 67: 1886-1893
27. Ladanyi M, Lewis R, Garin-Chesa P. et al EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diagn Mol Pathol 1993; 2: 141-146.
28. Kretschmar CW. Ewing's sarcoma and the 'Peanut' tumors. N Engl J Med 1994, 331: 325-327.
29. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993, 17: 1-13.
30. Schmidt D, Herrmann C, Jurgens H, Harms D Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma: a report from the Kiel Pediatric Tumor Registry Cancer 1991; 68: 2251-2259.
31. Burdagh S, Jurgens H, Peters C Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor prognosis Ewing's sarcoma J clin Oncol 1993; 11: 1482-1488.
32. Jurgens H, Bier V, Harms D, et al. Malignant peripheral neuroectodermal tumors: a retrospective analysis of 42 patients. Cancer 1988; 61: 1482-1488.
33. Miser JS, Kinsella TJ, Triche TJ, et al. Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol 1987; 5: 1752-1758.
34. Bolande RP. The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 1974; 5: 409-429.
35. Tonini GP. Neuroblastoma: a multiple biological disease. Eur J Cancer 1993; 29A: 802-804.
36. Brodeur GM, Fong C Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989; 41: 153-174.
37. Glass DJ, Yancopoulos GD. The neurotrophins and their receptors Trends Cell Biol 1993; 3: 262-268.
38. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM Association between high levels of expression of the TRK. gene and favourable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-854
39. Takeda O, Homma C, Maseki N, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma Gene Chromosome Cancer 1994, 10: 30-39
40. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Gene Chromosome Cancer 1994; 10: 275-281.
41. Brodeur GM. Seeger RC. Gene amplification in human neuroblastoma' basic mechanisms and clinical implications. Cancer Genet Cytogenet 1986; 19: 101-111.
42. Slave I, Ellenbogen R, Jung WH, et al. myc gene amplification and expression in primary human neuroblastoma Cancer Res 1990, 50: 1459-1463.
43. Fong CT, White PS, Peterson K, et al. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas Cancer Res 1992, 52: 1780-1785.
44. Hayashi Y, Kanda N, Inaba T, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 1989; 63: 126-132.
45. Brodeur GM. Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
46. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF Detection of Ip36 deletions in paraffin sections of neuroblastoma tissues. Gene Chromosome Cancer 1993; 6: 1-9.
47. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Mol Cell Probes 1993; 7: 227-234.
48. Boerner S, Squire J, Thorner P, McKenna G, Zielenska M. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Paediatr Pathol 1994, 14: 823-832.
49. Brodeur GM Molecular basis for heterogeneity in human neuroblastomas Eur J Cancer 1995, 31A: 505-509
50. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J. Intra-abdominal desmoplastic small round-cell tumor. Am J Surg Pathol 1991: 15:499-513.
51. Sawyer JR. Tryka AF, Lewis JM. A novel reciprocal chromosome translocation t(11;22)(p13,q12) in an intraabdominal desmoplastic small roundcell tumor. Am J Surg Pathol 1992; 16: 411-416.
52. Rodriguez E. Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RSK. A recurring translocation, t(11;22)(p13;q12), characterizes intraabdominal desmoplastic small round-cell rumors. Cancer Genet Cytogenet 1993; 69: 17-21.
53. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor Cancer Res 1994; 54: 2837-2840
54. Barr FG, Chatten J, D'Cruz CM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. J Am Med Assoc 1995; 273: 553-557.
55. Motzer RJ, Rodriguez E, Reuter VE, Bosl GJ, Mazumdar M, Chaganti RSK Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 1995; 13: 274-282.
56. Tsokos M, Webber BL, Parham DM, et al Rhabdomyosarcoma-a new classification scheme related to prognosis. Arch Pathol Lab Med 1992; 116: 847-855
57. Scrable H. Witte D, Shimada H, et al Molecular differential pathology of rhabdomyosarcoma. Gene Chromosome Cancer 1989; 1: 23-35.
58. Turc-Carel C, Lizard-Nacol S. Justrabo E, Favrot M, Philip T, Tabone E. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1986; 19: 361-362.
59. Buckingham M. Which myogenic factors make muscle? Curr Biol 1994; 4: 61-63
60. Davis RL, Weintraub H, Lassar AB Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987-1000.
61. Dias P, Parham DM, Shapiro DN, Webber BL, Houghton PJ. Myogenic regulatory protein (MyoDl) expression in childhood solid tumors; diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990; 137: 1283-1291.
62. Clark J, Rocques PJ, Braun T, et al Expression of members of the myf gene family in human rhabdomyosarcomas. Br J Cancer 1991; 64: 1049-1052
63. Dias P, Parham DM, Shapiro DN, Tapscott SJ. Houghton PJ. Monoclonal antibodies to the myogenic regulatory protein MyoDl. epitope mapping and diagnostic utility Cancer Res 1992, 52: 6431 6439.
64. Tallini G, Parham DM, Dias P, Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas. Am J Pathol 1994, 144: 693-701.
65. Wesche WA, Fletcher CDM, Dias P, Houghton PJ, Parham DM Immunohistochemistry of MyoDl in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995, 19: 261-269
66. Barlow DP. Methylation and imprinting: from host defence to gene regulation. Science 1993; 260: 309-310.
67. Karp JE, Broder S. New directions in molecular medicine. Cancer Res 1994; 54: 653-665.
68. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. Proc AACR 1994; 35: 3420a.
69. Sandberg AA, Bridge JA. The Cytogenetics of Bone and Soft Tissue Tumors. Austin R. G. Landes, 1994.
70. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel B. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993; 3: 113-117.
71. Galili N, Davis R, Fredericks W, et al Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993; 5: 230-235.
72. Fredericks WJ. Galili N. Mukhopadhyay S, et al The PAX3-FKHR fusion protein created by the t(2,13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol Cell Biol 1995; 15: 1522-1535.
73. Davis RJ, D'Cruz CM, Lovell MA. Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(1,13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994; 54: 2869-2872.
74. Biegel JA, Nycum LM, Valentine V, Bar FG, Shapiro DN Detection of the t(2,13)(q35,q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Gene Chromosome Cancer 1995, 12: 186-192
75. McManus AP, O'Reilly MJ, Pritchard-Jones K, et al Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) a diagnostic tool in minimally invasive biopsies. J Pathol (in press).
76. Downing JR. Khandekar A, Shurtleff SA, et al Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol 1995; 146: 626-634.
77. Douglass EC, Shapiro DN, Valentine M, Rowe ST Alveolar rhabdomyosarcoma with the t(2;13)- cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 1993; 21: 83-87.
78. Reboul-Marty J, Quintana E, Moseri V, el al. Prognostic factors of alveolar rhabdomyosarcoma in childhood: an International Society of Paediatric Oncology study. Cancer 1991: 68: 493-498.
79. Parham DM, Shapiro DN, Downing JR, Webber BL, Douglass EC. Solid alveolar rhabdomyosarcoma with the t(2;13). Report of two cases with diagnostic implications Am J Surg Pathol 1994; 18: 474-478
80. Pappos AS, Crist WM, Kuttesch J, et al Tumor-cell DNA content predicts outcome in children and adolescents with clinical groups III embryonal rhabdomyosarcoma. J Clin Oncol 1993; 10: 1901-1905.